CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (905) 475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-02 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Common Share Warrants (Right to Buy) | +4,444 | 4,444 | ||
| 2022-11-02 | NIFFENEGGER KATHI Chief Financial Officer | Grant or award · Common Share Warrants (Right to Buy) | +4,444 | 4,444 | ||
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award | +228,262 | $1.13 | $257K | 2,356,914 |
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award | +228,262 | $1.13 | $257K | 228,262 |
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Common Share Warrants (Right to Buy) | +114,131 | 114,131 | ||
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Common Share Warrants (Right to Buy) | +114,131 | 114,131 | ||
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Common Share Warrants (Right to Buy) | +114,131 | 114,131 | ||
| 2022-11-02 | Nijhawan Pardeep Chief Executive Officer | Grant or award · Common Share Warrants (Right to Buy) | +114,131 | 114,131 | ||
| 2022-06-30 | Nijhawan Pardeep Chief Executive Officer | Purchase | +20,000 | $1.60 | $32K | 594,812 |
| 2022-06-29 | Brooks Michael J President | Purchase | +3,000 | $1.49 | $4K | 26,241 |
| 2022-06-16 | Brooks Michael J President | Purchase | +3,000 | $1.61 | $5K | 23,241 |
| 2022-05-27 | Nijhawan Pardeep Chief Executive Officer | Purchase | +5,000 | $1.92 | $10K | 574,812 |
| 2022-05-25 | Brooks Michael J President | Purchase | +3,500 | $1.74 | $6K | 20,241 |
| 2022-05-24 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $1.80 | $4K | 569,812 |
| 2022-03-31 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $2.99 | $6K | 567,812 |
| 2022-03-30 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $3.05 | $6K | 565,812 |
| 2022-03-29 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $3.02 | $6K | 563,812 |
| 2022-03-28 | Chao Jennifer M Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2022-03-18 | Nijhawan Pardeep Chief Executive Officer | Purchase | +2,000 | $3.85 | $8K | 561,812 |
| 2022-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +397 | $3.25 | $1K | 558,209 |
Page 6 of 15 · 284 trades